Catalyst Pharma's total assets for Q1 2025 were $908.87M, an increase of 6.75% from the previous quarter. CPRX total liabilities were $114.59M for the fiscal quarter, a -7.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.